
    
      An intimate link between microbial infections, metabolic changes and oncogenesis has been
      drawn attentions increasingly, indicating a crossroad leading to pathogenesis and disease
      progression. Globally the burden of hepatitis B and C virus infections is 450 and 185
      millions, respectively and chronic hepatitis disease causes a high risk of liver cirrhosis,
      hepatocellular carcinoma and metabolic disorders
    
  